STOCK TITAN

Venu CEO buys 200,000 shares at $1.75

Venu Holding Corp (VENU) reports that CEO, Chairman and 10% owner Jay W. Roth purchased 200,000 shares of common stock on September 11, 2026 at $1.75 per share, in an open-market or private transaction through the JWR Living Trust.

(Moderate)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Venu Holding Corp (VENU) reports that CEO, Chairman and 10% owner Jay W. Roth purchased 200,000 shares of common stock on September 11, 2026 at $1.75 per share, in an open-market or private transaction through the JWR Living Trust.

After this purchase, the JWR Living Trust holds 262,500 shares, Mr. Roth holds 9,276,413 shares directly, and the KMR Living Trust holds 999,720 shares, all of which are deemed indirectly beneficially owned by him as trustee. No Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider ROTH JAY W
Role CEO & Chairman
Bought 200,000 shs ($350K)
Type Security Shares Price Value
Purchase Common Stock, par value $0.001 F1 200,000 $1.75 $350K
holding Common Stock, par value $0.001 -- -- --
holding Common Stock, par value $0.001 F2 -- -- --
Holdings After Transaction: Common Stock, par value $0.001 — 262,500 shares (Indirect, By JWR Living Trust dated November 19, 2012); Common Stock, par value $0.001 — 9,276,413 shares (Direct); Common Stock, par value $0.001 — 999,720 shares (Indirect, By KMR Living Trust dated November 19, 2012)
Footnotes (2)
  1. F1. These shares of common stock are owned directly by the JWR Living Trust dated November 19, 2012 (the "JWR Living Trust"), of which Mr. Jay W. Roth is a trustee. As a trustee, Mr. Roth is deemed to have indirect beneficial ownership of the securities held by the JWR Living Trust.
  2. F2. These shares of common stock are owned directly by the KMR Living Trust dated November 19, 2012 (the "KMR Living Trust"), of which Mr. Roth is a trustee. As a trustee, Mr. Roth is deemed to have indirect beneficial ownership of the shares held by the KMR Living Trust.
Shares purchased 200,000 shares Common stock purchased on September 11, 2026 via JWR Living Trust
Purchase price $1.75 per share Price for the 200,000-share purchase on September 11, 2026
JWR Living Trust holdings after transaction 262,500 shares Indirectly beneficially owned by Jay W. Roth as trustee
Direct holdings after transaction 9,276,413 shares Common stock held directly by Jay W. Roth
KMR Living Trust holdings 999,720 shares Indirectly beneficially owned by Jay W. Roth as trustee
indirect beneficial ownership financial
"Mr. Roth is deemed to have indirect beneficial ownership of the securities held"
Living Trust financial
"These shares of common stock are owned directly by the JWR Living Trust dated"
trustee financial
"of which Mr. Jay W. Roth is a trustee"
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VENU report for Jay W. Roth?

Jay W. Roth reported a purchase of 200,000 shares of Venu Holding Corp common stock on September 11, 2026 at $1.75 per share, executed through the JWR Living Trust in an open-market or private transaction.

How many VENU shares does Jay W. Roth own after this Form 4 transaction?

After the reported transaction, Jay W. Roth holds 9,276,413 shares directly. In addition, the JWR Living Trust holds 262,500 shares and the KMR Living Trust holds 999,720 shares, which he is deemed to own indirectly as trustee.

Was the VENU insider purchase made under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan was affirmed for the reported transactions, meaning they were not reported as being executed under a pre-arranged trading plan.

What type of security did Jay W. Roth buy in VENU?

Jay W. Roth bought Common Stock, par value $0.001 of Venu Holding Corp. The Form 4 reports a purchase of 200,000 shares at a price of $1.75 per share on September 11, 2026.

How are the JWR and KMR Living Trust holdings in VENU attributed to Jay W. Roth?

According to the filing, the JWR and KMR Living Trusts own their VENU shares directly, and Jay W. Roth is a trustee of each trust. As trustee, he is deemed to have indirect beneficial ownership of the shares held by those trusts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ROTH JAY W

(Last)(First)(Middle)
C/O VENU HOLDING CORPORATION
1755 TELSTAR DRIVE, SUITE 501

(Street)
COLORADO SPRINGS COLORADO 80920

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Venu Holding Corp [ VENU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
CEO & Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.0019,276,413D
Common Stock, par value $0.00109/11/2026P200,000A$1.75262,500IBy JWR Living Trust dated November 19, 2012(1)
Common Stock, par value $0.001999,720IBy KMR Living Trust dated November 19, 2012(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares of common stock are owned directly by the JWR Living Trust dated November 19, 2012 (the "JWR Living Trust"), of which Mr. Jay W. Roth is a trustee. As a trustee, Mr. Roth is deemed to have indirect beneficial ownership of the securities held by the JWR Living Trust.
2. These shares of common stock are owned directly by the KMR Living Trust dated November 19, 2012 (the "KMR Living Trust"), of which Mr. Roth is a trustee. As a trustee, Mr. Roth is deemed to have indirect beneficial ownership of the shares held by the KMR Living Trust.
/s/ Heather Atkinson, as attorney-in-fact for Jay W. Roth09/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading